Integrating Index Lesion Volume to Better Classify Men with Indolent Prostate Cancer among Patients with Intermediate Risk Disease. Results from a Large, Multi-Institutional Series
Armando Stabile,Giorgio Gandaglia,Francesco Pellegrino,Elio Mazzone,Vito Cucchiara,Nicola Fossati,Marco Moschini,Agostino Mattei,Luca Afferi,Sergio Serni,Andrea Minervini,Razvan-George Rahota,Guillaume Ploussard,Massimo Valerio,Jean Baptiste Beavaul,Alessandro Marquis,Arnas Rakauskas,Paolo Gontero,Hongqian Guo,Junlong Zhuang,Roderick Van den Bergh,Timo Soeterik,Francesco Montorsi,Alberto Briganti
DOI: https://doi.org/10.1016/s0302-2838(23)00147-1
IF: 7.6
2023-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyCME1 Apr 2023PD39-06 INTEGRATING INDEX LESION VOLUME TO BETTER CLASSIFY MEN WITH INDOLENT PROSTATE CANCER AMONG PATIENTS WITH INTERMEDIATE RISK DISEASE. RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES Armando Stabile, Giorgio Gandaglia, Francesco Pellegrino, Elio Mazzone, Vito Cucchiara, Nicola Fossati, Marco Moschini, Agostino Mattei, Luca Afferi, Sergio Serni, Andrea Minervini, Razvan-George Rahota, Guillaume Ploussard, Massimo Valerio, Jean Baptiste Beavaul, Alessandro Marquis, Arnas Rakauskas, Paolo Gontero, Hongqian Guo, Junlong Zhuang, Roderick Van Den Bergh, Timo Soeterik, Francesco Montorsi, and Alberto Briganti Armando StabileArmando Stabile More articles by this author , Giorgio GandagliaGiorgio Gandaglia More articles by this author , Francesco PellegrinoFrancesco Pellegrino More articles by this author , Elio MazzoneElio Mazzone More articles by this author , Vito CucchiaraVito Cucchiara More articles by this author , Nicola FossatiNicola Fossati More articles by this author , Marco MoschiniMarco Moschini More articles by this author , Agostino MatteiAgostino Mattei More articles by this author , Luca AfferiLuca Afferi More articles by this author , Sergio SerniSergio Serni More articles by this author , Andrea MinerviniAndrea Minervini More articles by this author , Razvan-George RahotaRazvan-George Rahota More articles by this author , Guillaume PloussardGuillaume Ploussard More articles by this author , Massimo ValerioMassimo Valerio More articles by this author , Jean Baptiste BeavaulJean Baptiste Beavaul More articles by this author , Alessandro MarquisAlessandro Marquis More articles by this author , Arnas RakauskasArnas Rakauskas More articles by this author , Paolo GonteroPaolo Gontero More articles by this author , Hongqian GuoHongqian Guo More articles by this author , Junlong ZhuangJunlong Zhuang More articles by this author , Roderick Van Den BerghRoderick Van Den Bergh More articles by this author , Timo SoeterikTimo Soeterik More articles by this author , Francesco MontorsiFrancesco Montorsi More articles by this author , and Alberto BrigantiAlberto Briganti More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003342.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Optimal treatment in men with intermediate (IM) risk prostate cancer (PCa) is still a matter of debate. MRI has improved pre-treatment risk stratification and PCa volume estimation. However, index lesion (IL) volume, which is associated with oncological outcome, is still not included in patient risk assessment. We hypothesise that men with indolent PCa among patients with IM risk disease can be identified by adding MRI IL volume in a large contemporary cohort of men treated with radical prostatectomy (RP). METHODS: We identified 3088 patients with low and IM PCa receiving RP at 11 referral centres. All patients had a positive MRI (PIRADS≥3). The aim was to compare oncological outcomes of low risk ISUP 1 PCa (Group 1) and IM risk ISUP 2-3 PCa, stratified according to the most informative IL volume cut-off at MRI, namely IL diameter <10 mm (Group 2) and ≥10 mm (Group 3). The outcome of this study was biochemical recurrence (BCR) after RP. Multivariable Cox regression analyses (MVA) were used to compare BCR-free survival in Group 1 vs 2 vs 3 after accounting for the following confounders: PSA, prostate volume, PIRADS score, and percent of positive biopsy cores. We then compared BCR-free survival using the adjusted Kaplan-Meier method (KM). RESULTS: 247 (8%), 1747 (57%), and 1094 (35%) patients harboured ISUP group 1, 2, and 3 at RP, respectively. In all, 247 (8%), 2110 (68%), and 731 (24%) patients were stratified into Group 1, 2, and 3, respectively. Median follow-up was 50 months and 227 patients had BCR. The 5-yr BCR-free survival probability was 84%, 86%, and 73%, among patients in group 1, 2, and 3, respectively (Figure 1; p<0.01). At MVA, with Group 1 as reference, only Group 3 was associated with the rate of BCR (Group 2: HR: 0.94, p=0.9; Group 3: HR: 2.32, p=0.03). Specifically, patients with PCa ISUP 1 and PCa ISUP 2-3 with IL <10 mm did not exhibit any differences in BCR-free survival after RP (p=0.6) (Figure 1). CONCLUSIONS: Patients with low volume ISUP 2-3 with IL size <10 mm appear to have comparable oncological outcomes in terms of BCR-free survival to patients with ISUP 1 disease after RP. These results should be taken into account for patient counselling and in decision making of active treatment vs active surveillance in patients with low volume IM risk PCa. Source of Funding: NA © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e1047 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Armando Stabile More articles by this author Giorgio Gandaglia More articles by this author Francesco Pellegrino More articles by this author Elio Mazzone More articles by this author Vito Cucchiara More articles by this author Nicola Fossati More articles by this author Marco Moschini More articles by this author Agostino Mattei More articles by this author Luca Afferi More articles by this author Sergio Serni More articles by this author Andrea Minervini More articles by this author Razvan-George Rahota More articles by this author Guillaume Ploussard More articles by this author Massimo Valerio More articles by this author Jean Baptiste Beavaul More articles by this author Alessandro Marquis More articles by this author Arnas Rakauskas More articles by this author Paolo Gontero More articles by this author Hongqian Guo More articles by this author Junlong Zhuang More articles by this author Roderick Van Den Bergh More articles by this author Timo Soeterik More articles by this author Francesco Montorsi More articles by this author Alberto Briganti More articles by this author Expand All Advertisement PDF downloadLoading ...